Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity
18
F-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease
Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of
PET in Therapeutic Response Assessment
Treatment Planning for Radiation Therapy
Prognostic Value of 18F-Fluorodeoxyglucose PET/Computed Tomography in
Non-Small-Cell Lung Cancer
Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose
Future Directions in PET Imaging of Lung Cancer
Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET
Imaging
Practical Considerations for Clinical PET/MR Imaging
Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer